The United States diagnostics market size is anticipated to grow at a CAGR of 5.17% during the forecast period of 2024-2032 driven by the rising awareness among people about healthy lifestyle.
When a disease or condition is checked or analyzed by a healthcare professional, it is generally termed as diagnosing the condition, where diagnostics refers to the processes that are used to conclude the outcome on that analysis. With the help of diagnostic tests several diseases and medical conditions are detected and treated with the right treatment approach when diagnosed.
By detecting a disease on time, it becomes easy to treat it on time as it helps in knowing details about the disease like how fatal or normal a condition is and what are the measure that a patient can take to prevent it in future.
There are several key trends justifying the growth of the market, including the increasing involvement of advanced technologies in the diagnostics field, such as risk analysis and pattern recognition, among others. The increasing demand for point-of-care testing POCT has also been driving the market growth.
Additionally, the development of easy-to-use diagnostics devices is also acting as a trend and has been aiding the United States diagnostics market expansion. Due to the increasing and advancing use of technologies like polymerase chain reaction (PCR), next-generation sequencing (NGS), and personalized diagnostic testing, the market is expected to witness significant growth. The increasing integration of smart technologies such as artificial intelligence (AI) and machine learning (ML) in the diagnostic field of healthcare is expected to revolutionize the market.
The arrival of Digital pathology (DP) in the market is a great action and is significantly aiding the United States diagnostics market development. Digital pathology offers several benefits and has an extended scope of applications. These benefits include easy sharing features with which sharing of slides worldwide is just as simple as sending documents with smartphone.
Market Breakup by Product Type
Market Breakup by Technique
Market Breakup by Usage
Market Breakup by Applications
Market Breakup by End User
United States is the largest diagnostics market globally owing to factors like the rising awareness among people about healthy lifestyle and taking their healthcare serious. The increasing geriatric population, along with multiple diseases in this age, are also a major driver for the United States diagnostics market growth.
Additionally, being the largest market across the globe, the high development rate with advanced technologies to improve the quality and performance of the diagnostic methods and equipment is also a major driver for the market. The increasing emphasis on consuming personalized medicines that involves tailoring medical treatments in accordance to the individual patients' unique characteristics, has significantly increased the demand for advanced diagnostic tests. Molecular diagnostics and genetic testing are critical components of personalized medicine that makes the existence of targeted therapies and precise treatment decisions possible and reliable.
Due to the high healthcare expenditure per capita, driven by factors such as increased healthcare access, insurance coverage, and a focus on quality healthcare delivery, the demand for diagnostics services is on a rise. This is directly linked to healthcare expenditure because accurate and timely diagnosis is fundamental to effective healthcare delivery and cost management.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
|Scope of the Report||
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|Breakup by Product Type||
|Breakup by Technique||
|Breakup by Usage||
|Breakup by Applications||
|Breakup by End User||
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 United States Diagnostics Market Overview
3.1 United States Diagnostics Market Historical Value (2017-2023)
3.2 United States Diagnostics Market Forecast Value (2024-2032)
4 United States Diagnostics Market Landscape
4.1 United States Diagnostics Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 United States Diagnostics Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Applications
5 United States Diagnostics Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 United States Diagnostics Market Segmentation
6.1 United States Diagnostics Market by Product Type
6.1.1 Market Overview
6.1.4 Software and Services
6.2 United States Diagnostics Market by Technique
6.2.1 Market Overview
6.2.3 Clinical Techniques
6.2.4 Molecular Diagnostics
6.2.5 Tissue Diagnostics
6.3 United States Diagnostics Market by Usage
6.3.1 Market Overview
6.4 United States Diagnostics Market by Applications
6.4.1 Market Overview
6.4.2 Infectious Diseases
220.127.116.11 Human Papillomavirus
18.104.22.168 Hospital-Acquired Infections
22.214.171.124 Breast Cancer
126.96.36.199 Lung Cancer
188.8.131.52 Colorectal Cancer
184.108.40.206 Liver Cancer
6.4.4 Sexually Transmitted Diseases
220.127.116.11 Chlamydia Trachomatis Infection
6.5 United States Diagnostics Market by End User
6.5.1 Market Overview
6.5.3 Public labs
6.5.4 Diagnostic Centers
6.5.5 Point-of-Care Testing Centers
6.5.6 Private or Commercial Laboratories
7 Patent Analysis
7.1 Analysis by Type of Patent
7.2 Analysis by Publication year
7.3 Analysis by Issuing Authority
7.4 Analysis by Patent Age
7.5 Analysis by CPC Analysis
7.6 Analysis by Patent Valuation
7.7 Analysis by Key Players
8 Grants Analysis
8.1 Analysis by year
8.2 Analysis by Amount Awarded
8.3 Analysis by Issuing Authority
8.4 Analysis by Grant Application
8.5 Analysis by Funding Institute
8.6 Analysis by NIH Departments
8.7 Analysis by Recipient Organization
9 Funding Analysis
9.1 Analysis by Funding Instances
9.2 Analysis by Type of Funding
9.3 Analysis by Funding Amount
9.4 Analysis by Leading Players
9.5 Analysis by Leading Investors
9.6 Analysis by Geography
10 Partnership and Collaborations Analysis
10.1 Analysis by Partnership Instances
10.2 Analysis by Type of Partnership
10.3 Analysis by Leading Players
10.4 Analysis by Geography
11 Regulatory Framework
11.1 Regulatory Overview
11.1.1 US FDA
11.1.2 EU EMA
11.1.3 INDIA CDSCO
11.1.4 JAPAN PMDA
12 Supplier Landscape
12.1 Abbott Laboratories, Inc.
12.1.1 Financial Analysis
12.1.2 Product Portfolio
12.1.3 Demographic Reach and Achievements
12.1.4 Mergers and Acquisitions
12.2 Danaher Corporation
12.2.1 Financial Analysis
12.2.2 Product Portfolio
12.2.3 Demographic Reach and Achievements
12.2.4 Mergers and Acquisitions
12.3 Thermo Fisher Scientific, Inc.
12.3.1 Financial Analysis
12.3.2 Product Portfolio
12.3.3 Demographic Reach and Achievements
12.3.4 Mergers and Acquisitions
12.4 Johnson & Johnson
12.4.1 Financial Analysis
12.4.2 Product Portfolio
12.4.3 Demographic Reach and Achievements
12.4.4 Mergers and Acquisitions
12.5 Ortho-Clinical Diagnostics, Inc.
12.5.1 Financial Analysis
12.5.2 Product Portfolio
12.5.3 Demographic Reach and Achievements
12.5.4 Mergers and Acquisitions
12.6 Becton, Dickinson, and Company
12.6.1 Financial Analysis
12.6.2 Product Portfolio
12.6.3 Demographic Reach and Achievements
12.6.4 Mergers and Acquisitions
12.7 Bio-Rad Laboratories, Inc.
12.7.1 Financial Analysis
12.7.2 Product Portfolio
12.7.3 Demographic Reach and Achievements
12.7.4 Mergers and Acquisitions
12.8 Roche Diagnostics Corporation
12.8.1 Financial Analysis
12.8.2 Product Portfolio
12.8.3 Demographic Reach and Achievements
12.8.4 Mergers and Acquisitions
12.9 Siemens Medical Solutions USA, Inc.
12.9.1 Financial Analysis
12.9.2 Product Portfolio
12.9.3 Demographic Reach and Achievements
12.9.4 Mergers and Acquisitions
12.10 Biomerieux Inc.
12.10.1 Financial Analysis
12.10.2 Product Portfolio
12.10.3 Demographic Reach and Achievements
12.10.4 Mergers and Acquisitions
13 United States Diagnostics Market - Distribution Model (Additional Insight)
13.2 Potential Distributors
13.3 Key Parameters for Distribution Partner Assessment
14 Key Opinion Leaders (KOL) Insights (Additional Insight)
15 Company Competitiveness Analysis (Additional Insight)
15.1 Very Small Companies
15.2 Small Companies
15.3 Mid-Sized Companies
15.4 Large Companies
15.5 Very Large Companies
16 Payment Methods (Additional Insight)
16.1 Government Funded
16.2 Private Insurance
*Additional insights provided are customisable as per client requirements.
The market is anticipated to grow at a CAGR of 5.17% during the forecast period of 2024-2032.
The key drivers for the market growth include the rising prevalence of various disorders and ailments, along with the rising awareness among people about healthy lifestyle.
The different product types in the market are reagents, instruments, software, and services.
The different techniques in the market are immunodiagnostics, clinical techniques, molecular diagnostics, and tissue diagnostics, among others.
It finds wide application in infectious diseases, cancer, and sexually transmitted diseases.
The different end users in the market include hospitals, public labs, diagnostic centers, point-of-care testing centers, private or commercial laboratories, among others.
The increasing demand for point-of-care testing POCT is among the major trends in the market.
Key players involved in the market are Abbott Laboratories, Inc., Danaher Corporation, Thermo Fisher Scientific, Inc., Johnson & Johnson, Ortho-Clinical Diagnostics, Inc., Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc., Roche Diagnostics Corporation, Inc., Biomerieux Inc., and Siemens Medical Solutions USA.
Single User License
Five User License
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.